Table 2.
Demographic, Clinical, and Symptom Characteristics of the Patients (n=586)
| Demographic Characteristics | |
| Age (years; mean (SD)) | 57.2 (11.9) |
| Gender (% female (n)) | 80.0 (469) |
| Ethnicity (% (n)) | |
| White | 69.3 (406) |
| Black Non-Hispanic | 7.0 (41) |
| Asian/Pacific Islander | 12.8 (75) |
| Hispanic/Mixed/Other | 10.9 (64) |
| Education (years; mean (SD)) | 16.3 (3.0) |
| Married or partnered (% yes (n)) | 67.7 (397) |
| Lives alone (% yes (n)) | 19.8 (116) |
| Currently employed (% yes (n)) | 34.3 (201) |
| Child care responsibilities (% yes (n)) | 22.9 (134) |
| Income (% yes (n)) | |
| Less than $30,000 | 18.7 (98) |
| $30,000 to <$70,000 | 17.8 (104) |
| $70,000 to < $100,000 | 15.2 (89) |
| More than $100,000 | 39.9 (234) |
| Clinical Characteristics | |
| Self-administered Comorbidity Questionnaire score (mean (SD)) | 5.6 (3.0) |
| Body mass index (kg/m2; mean (SD)) | 26.3 (5.8) |
| Hemoglobin (gm/dL; mean (SD)) | 11.7 (1.4) |
| Karnofsky Performance Status score (mean (SD)) | 80.6 (11.8) |
| Exercise on a regular basis (% yes (n)) | 70.5 (413) |
| Specific comorbidities reported (% yes (n)) | |
| High blood pressure | 31.4 (184) |
| Back pain | 27.0 (158) |
| Depression | 20.5 (120) |
| Osteoarthritis | 13.7 (80) |
| Anemia or blood disease | 12.1 (71) |
| Lung disease | 9.9 (58) |
| Diabetes | 8.7 (51) |
| Liver disease | 6.8 (40) |
| Heart disease | 5.5 (32) |
| Rheumatoid arthritis | 4.1 (24) |
| Ulcer or stomach disease | 4.1 (24) |
| Kidney disease | 1.2 (7) |
| Cancer diagnosis (% yes (n)) | |
| Breast | 42.8 (251) |
| Gastrointestinal | 26.8 (157) |
| Gynecological | 20.3 (119) |
| Lung | 10.1 (59) |
| Time since cancer diagnosis (years; mean (SD)) | 2.5 (4.4) |
| Time since cancer diagnosis (years; median) | 0.49 |
| Any prior cancer treatments (% yes (n)) | 82.4 (483) |
| Number prior cancer treatments (mean (SD)) | 1.9 (1.6) |
| Type of prior cancer treatment (% yes (n)) | |
| No prior treatment | 17.6 (103) |
| Only surgery, chemotherapy, or RT | 40.4 (237) |
| Surgery and chemotherapy, or surgery and RT, or chemotherapy and RT | 23.0 (135) |
| Surgery and chemotherapy and RT | 17.7 (104) |
| Chemotherapy cycle length (% (n)) | |
| 14 days | 36.0 (211) |
| 21 days | 55.3 (324) |
| 28 days | 8.7 (51) |
| Number of metastatic sites including lymph node involvement (mean (SD)) | 1.4 (1.3) |
| Number of metastatic sites excluding lymph node involvement (mean (SD)) | 0.9 (1.2) |
| Symptom Characteristics at Enrollment | |
| Lee Fatigue Scale: evening fatigue score (mean (SD)) | 5.3 (2.1) |
| Lee Fatigue Scale: morning fatigue score (mean (SD)) | 3.1 (2.2) |
| Lee Fatigue Scale: evening energy score (mean (SD)) | 3.5 (1.9) |
| Lee Fatigue Scale: morning energy score (mean (SD)) | 4.5 (2.2) |
| Center for Epidemiological Studies-Depression Scale score (mean (SD)) | 12.6 (9.4) |
| General Sleep Disturbance Scale score (mean (SD)) | 52.2 (19.4) |
| Trait Anxiety score (mean (SD)) | 35.0 (10.4) |
| State Anxiety score (mean (SD)) | 33.2 (12.1) |
| Pain present (% yes (n)) | 73.5 (431) |
Abbreviations: gm/dL = grams per deciliter; kg/m2 = kilograms per meters squared; SD = standard deviation; RT = radiation therapy.